Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success

Rachel Burton, Maria Puthoor, Fred Fyles, Lisa Lewis, Hannah Joplin, Hassan Burhan

Open source

DOI
10.1136/bmjresp-2026-004232
Published
2026-07
Container
BMJ Open Respiratory Research
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjresp-2026-004232,
  title = {Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success},
  author = {Rachel Burton and Maria Puthoor and Fred Fyles and Lisa Lewis and Hannah Joplin and Hassan Burhan},
  year = {2026},
  journal = {BMJ Open Respiratory Research},
  doi = {10.1136/bmjresp-2026-004232},
  url = {https://doi.org/10.1136/bmjresp-2026-004232}
}

RIS

TY  - JOUR
TI  - Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success
AU  - Rachel Burton
AU  - Maria Puthoor
AU  - Fred Fyles
AU  - Lisa Lewis
AU  - Hannah Joplin
AU  - Hassan Burhan
PY  - 2026
JO  - BMJ Open Respiratory Research
DO  - 10.1136/bmjresp-2026-004232
UR  - https://doi.org/10.1136/bmjresp-2026-004232
ER  - 

APA

Burton, R., Puthoor, M., Fyles, F., Lewis, L., Joplin, H., & Burhan, H. (2026). Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success. BMJ Open Respiratory Research. https://doi.org/10.1136/bmjresp-2026-004232

Source records